No Data
US Stock MarketDetailed Quotes
PFE Pfizer
Watchlist
32.980
+0.290+0.89% Close 09/25 16:00 ET
32.950-0.030-0.09%
Post 19:59 ET
32.980High32.410Low19.44MVolume
32.690Open32.690Pre Close637.46MTurnover0.35%Turnover Ratio8.79P/E (TTM)186.20BMarket Cap53.25452wk High6.03P/E (Static)5.65BShares32.41052wk Low1.88P/B186.03BFloat Cap57.944Historical High1.62Dividend TTM5.64BShs Float5.800Historical Low4.91%Div YieldTTM1.74%Amplitude32.785Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Revenue Breakdown
Business
Unit:USD
12/31/2022
Stock NameRevenueRatio
Biopharma98.99B98.66%
Other business activities1.34B1.34%
News
Unusual Options Activity: SNAP, TXN and Others Attract Market Bets, SNAP V/OI Ratio Reaches 307.7
EST Sep 25th Afternoon Delivery - In the last 2 hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Tornado-damaged Pfizer Plant in North Carolina Restarts Production
Express News | Pfizer Says To Intermittently Distribute Extra Inventory Not Necessary For Maintaining Emergency Order Process To Wholesalers, Distributors; First Shipments To Centers Of 13 Medicines In Production On The Lines That Have Restarted Anticipated In Q4
Comments
ColumnsThe $60 billion weight loss drug market: which pharmaceutical companies can benefit?
Follow me on Moomoo to stay informed and connected!
01 What is GLP-1 weight loss drug?
GLP-1 weight loss drugs, full name Glucagon-like peptide-1 receptor agonists (GLP-1). Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used to treat diabetes. However, researchers discovered over time that this hormone can suppress appetite and therefore control weight. Hence, major pharmaceutical co...
01 What is GLP-1 weight loss drug?
GLP-1 weight loss drugs, full name Glucagon-like peptide-1 receptor agonists (GLP-1). Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used to treat diabetes. However, researchers discovered over time that this hormone can suppress appetite and therefore control weight. Hence, major pharmaceutical co...
3
T2 Biosystems: The Diagnostic Dynamo Shaping the Future
$T2 Biosystems(TTOO.US$
**1. Tackling Global Health Threats Head-On**
**A. A Leap in Sepsis Detection:** T2 Biosystems made waves by securing FDA clearance for its sepsis-detecting test that identifies pathogens directly from whole blood samples, eliminating the delay of blood cultures. Given that sepsis is a leading cause of death in hospitals, this could be a game-changer, potentially saving countless lives.
**B. Confronting Antibiotic ...
**1. Tackling Global Health Threats Head-On**
**A. A Leap in Sepsis Detection:** T2 Biosystems made waves by securing FDA clearance for its sepsis-detecting test that identifies pathogens directly from whole blood samples, eliminating the delay of blood cultures. Given that sepsis is a leading cause of death in hospitals, this could be a game-changer, potentially saving countless lives.
**B. Confronting Antibiotic ...
9
9
ColumnsPfizer plans to drive its future development through diversification, cost reduction, and growth | Pfizer Inc. (PFE) JPMorgan 14th Annual U.S. All Stars Conference (Transcript)
SUMMARY
1. Pfizer discussed their position as a company during the transition from the pandemic stage and COVID revenue to a more diversified company with investments in M&A, business development, and oncology. They have a pipeline of products expected to generate over $20 billion in revenue by 2030.
2. Pfizer spoke about ...
1. Pfizer discussed their position as a company during the transition from the pandemic stage and COVID revenue to a more diversified company with investments in M&A, business development, and oncology. They have a pipeline of products expected to generate over $20 billion in revenue by 2030.
2. Pfizer spoke about ...
1
2
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--